Egaptivon pegol Terminated Phase 2 Trials for Thrombotic Thrombocytopenic Purpura (TTP) / Thrombotic Microangiopathies Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00726544Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy